• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组关联研究证实 与泰国患者抗结核药物性肝损伤易感性的关联。

Genomewide Association Study Confirming the Association of with Susceptibility to Antituberculosis Drug-Induced Liver Injury in Thai Patients.

机构信息

Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

出版信息

Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.02692-18. Print 2019 Aug.

DOI:10.1128/AAC.02692-18
PMID:31109976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6658740/
Abstract

Antituberculosis drug-induced liver injury (ATDILI) is a common side effect leading to tuberculosis (TB) treatment disruption. The mechanism of the disease remains poorly understood. We conducted a genomewide association study (GWAS) to investigate all possible genetic factors of ATDILI in Thai patients. This study was carried out in Thai TB patients, including 79 ATDILI cases and 239 tolerant controls from our network hospitals in Thailand. Nearly 1 million single-nucleotide polymorphisms (SNPs) were genotyped across the whole genome using an Illumina OmniExpress Exome BeadChip array. In the discovery stage, we identified strong association signals on chromosome 8 originating from the -acetyltransferase () region. The A allele of rs1495741, the top SNP in the intergenic region of and (14 kb from ), was significantly associated with ATDILI (recessive model, odds ratio of 6.01 [95% confidence interval, 3.42 to 10.57];  = 6.86E-11). This particular SNP was reported as a tag SNP for inferred phenotypes. The AA, AG, and GG genotypes represented slow acetylators, intermediate acetylators, and fast acetylators, respectively. The tag SNP genotypes demonstrated a concordance rate of 94.98% with acetylator phenotypes. This GWAS shows that is the most important risk factor for ATDILI in the Thai population.

摘要

抗结核药物性肝损伤(ATDILI)是导致结核病(TB)治疗中断的常见副作用。该疾病的发病机制仍不清楚。我们进行了全基因组关联研究(GWAS),以研究泰国患者中可能导致 ATDILI 的所有遗传因素。这项研究在泰国的结核病患者中进行,包括 79 例 ATDILI 病例和 239 例来自我们在泰国网络医院的耐受对照。使用 Illumina OmniExpress Exome BeadChip 阵列在全基因组范围内对近 100 万个单核苷酸多态性(SNP)进行了基因分型。在发现阶段,我们在 8 号染色体上发现了源自乙酰基转移酶()区域的强烈关联信号。rs1495741 的 A 等位基因,位于 和 (14 kb 来自)基因间区域的顶级 SNP,与 ATDILI 显著相关(隐性模型,比值比为 6.01 [95%置信区间,3.42 至 10.57];= 6.86E-11)。该特定 SNP 被报道为推断表型的 标签 SNP。AA、AG 和 GG 基因型分别代表慢乙酰化者、中间乙酰化者和快乙酰化者。标签 SNP 基因型与 乙酰化表型的符合率为 94.98%。这项 GWAS 表明,在泰国人群中,是 ATDILI 的最重要危险因素。

相似文献

1
Genomewide Association Study Confirming the Association of with Susceptibility to Antituberculosis Drug-Induced Liver Injury in Thai Patients.全基因组关联研究证实 与泰国患者抗结核药物性肝损伤易感性的关联。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.02692-18. Print 2019 Aug.
2
NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.NAT2慢乙酰化者与泰国患者抗结核药物性肝损伤相关。
Int J Tuberc Lung Dis. 2016 Oct;20(10):1364-1369. doi: 10.5588/ijtld.15.0310.
3
NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.N-乙酰转移酶2超慢乙酰化者与抗结核药物性肝损伤风险:一项基于基因型的荟萃分析。
Pharmacogenet Genomics. 2018 Jul;28(7):167-176. doi: 10.1097/FPC.0000000000000339.
4
The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity.NAT2 标签 SNP rs1495741 与抗结核药物性肝损伤的易感性相关。
Pharmacogenet Genomics. 2013 Apr;23(4):200-7. doi: 10.1097/FPC.0b013e32835e95e1.
5
N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.印度人群中N-乙酰转移酶和细胞色素P450 2E1基因多态性与抗结核药物肝毒性易感性
Natl Med J India. 2013 Sep-Oct;26(5):260-5.
6
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.N-乙酰转移酶2基因多态性作为突尼斯结核病患者抗结核药物性肝毒性的易感性危险因素。
Pathol Biol (Paris). 2012 Oct;60(5):324-30. doi: 10.1016/j.patbio.2011.07.001.
7
tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity.标签单核苷酸多态性rs1495741作为预测抗结核药物性肝毒性的有用分子标志物。
Pharmacogenet Genomics. 2016 Jul;26(7):357-61. doi: 10.1097/FPC.0000000000000224.
8
N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group.N-乙酰基转移酶2(NAT2)基因型作为混合种族患者群体中与抗结核药物治疗相关的药物性肝损伤发生的危险因素。
Eur J Clin Pharmacol. 2014 Sep;70(9):1079-86. doi: 10.1007/s00228-014-1703-0. Epub 2014 Jun 3.
9
[The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].N-乙酰转移酶2基因多态性与肺结核患者抗结核药物性肝损伤的相关性
Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Jan;45(1):36-40.
10
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.N-乙酰转移酶2基因多态性作为抗结核药物性肝炎的易感性危险因素。
Hepatology. 2002 Apr;35(4):883-9. doi: 10.1053/jhep.2002.32102.

引用本文的文献

1
Genetic and Genomic Approaches to the Study of Drug-Induced Liver Injury.药物性肝损伤研究的遗传和基因组学方法。
Liver Int. 2025 Jan;45(1):e16191. doi: 10.1111/liv.16191.
2
A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data.一个全面的泰国药物基因组学数据库(TPGxD-1):在 942 个全基因组测序数据中的表型预测和变异识别。
Clin Transl Sci. 2024 Jun;17(6):e13830. doi: 10.1111/cts.13830.
3
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity.铜的协同毒性导致 NAT2 相关异烟肼毒性。
Exp Mol Med. 2024 Mar;56(3):570-582. doi: 10.1038/s12276-024-01172-8. Epub 2024 Mar 1.
4
Non-coding and intergenic genetic variants of human arylamine -acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders.人类芳胺-N-乙酰基转移酶2(NAT2)基因的非编码和基因间遗传变异与血浆脂质和胆固醇水平差异以及心脏代谢紊乱有关。
Front Pharmacol. 2023 Apr 3;14:1091976. doi: 10.3389/fphar.2023.1091976. eCollection 2023.
5
Relevance of Pharmacogenomics to the Safe Use of Antimicrobials.药物基因组学与抗菌药物安全使用的相关性
Antibiotics (Basel). 2023 Feb 21;12(3):425. doi: 10.3390/antibiotics12030425.
6
Genetics of drug-induced liver injury: Current knowledge and future prospects.药物性肝损伤的遗传学:现有知识和未来展望。
Clin Transl Sci. 2023 Jan;16(1):37-42. doi: 10.1111/cts.13424. Epub 2022 Oct 4.
7
PSD3 downregulation confers protection against fatty liver disease.PSD3 下调可防止脂肪性肝病。
Nat Metab. 2022 Jan;4(1):60-75. doi: 10.1038/s42255-021-00518-0. Epub 2022 Jan 31.
8
, , and genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients.泰国结核病患者中 、 和 的基因多态性及其与抗结核药物性肝损伤易感性的关联。
Heliyon. 2021 Apr 20;7(4):e06852. doi: 10.1016/j.heliyon.2021.e06852. eCollection 2021 Apr.
9
Functional Characterization of the Effects of -acetyltransferase 2 Alleles on -acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity.N-乙酰基转移酶2等位基因对8种药物N-乙酰化作用的功能特性及底物特异性差异的全球分布
Front Genet. 2021 Mar 18;12:652704. doi: 10.3389/fgene.2021.652704. eCollection 2021.
10
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice.药物性肝损伤(DILI)中的氧化应激:从机制到临床实践中使用的生物标志物
Antioxidants (Basel). 2021 Mar 5;10(3):390. doi: 10.3390/antiox10030390.

本文引用的文献

1
NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.NAT2慢乙酰化者与泰国患者抗结核药物性肝损伤相关。
Int J Tuberc Lung Dis. 2016 Oct;20(10):1364-1369. doi: 10.5588/ijtld.15.0310.
2
Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.抗结核药物性肝毒性的全基因组关联及重复研究
BMC Genomics. 2016 Sep 26;17(1):755. doi: 10.1186/s12864-016-3078-3.
3
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.美国胸科学会/疾病控制与预防中心/美国传染病学会官方临床实践指南:药物敏感型肺结核的治疗
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.
4
Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients.日本患者抗结核药物性肝损伤预测系统的开发。
Hum Genome Var. 2016 Jun 23;3:16014. doi: 10.1038/hgv.2016.14. eCollection 2016.
5
Single nucleotide polymorphism coverage and inference of N-acetyltransferase-2 acetylator phenotypes in wordwide population groups.全球人群组中N-乙酰转移酶-2乙酰化表型的单核苷酸多态性覆盖范围及推断
Pharmacogenet Genomics. 2016 Aug;26(8):363-9. doi: 10.1097/FPC.0000000000000225.
6
tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity.标签单核苷酸多态性rs1495741作为预测抗结核药物性肝毒性的有用分子标志物。
Pharmacogenet Genomics. 2016 Jul;26(7):357-61. doi: 10.1097/FPC.0000000000000224.
7
Second-generation PLINK: rising to the challenge of larger and richer datasets.第二代PLINK:应对更大、更丰富数据集的挑战
Gigascience. 2015 Feb 25;4:7. doi: 10.1186/s13742-015-0047-8. eCollection 2015.
8
Superoxide Dismutase Gene (SOD1, SOD2, and SOD3) Polymorphisms and Antituberculosis Drug-induced Hepatitis.超氧化物歧化酶基因(SOD1、SOD2 和 SOD3)多态性与抗结核药物性肝炎。
Allergy Asthma Immunol Res. 2015 Jan;7(1):88-91. doi: 10.4168/aair.2015.7.1.88. Epub 2014 Sep 25.
9
An atlas of genetic influences on human blood metabolites.人类血液代谢物遗传影响图谱。
Nat Genet. 2014 Jun;46(6):543-550. doi: 10.1038/ng.2982. Epub 2014 May 11.
10
Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.异烟肼诱导的特异质性肝损伤机制:线粒体应激的新作用
J Gastroenterol Hepatol. 2014 Apr;29(4):678-87. doi: 10.1111/jgh.12516.